Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Pharmacopeia and Otsuka enter drug discovery collaboration

Nov. 18, 1999

Genetronics and Boehringer Ingelheim enter collaborative gene therapy agreement

Nov. 12, 1999

CombiChem reaches second milestone in collaboration with Teijin

Nov. 10, 1999

Exelixis and Pharmacia & Upjohn expand collaboration

Nov. 10, 1999

ASN presentation for VNA-932, a potent and selective, nonpeptide V2 agonist

Nov. 9, 1999

Helix BioPharma finalizes acquisition of PharmaDerm

Nov. 9, 1999

Idun identifies X-ray structure of caspase 8

Nov. 8, 1999

Abgenix and Pfizer add third antigen target to collaboration agreement

Nov. 5, 1999

HepaVec and CSIRO sign option agreement for ovine viral vector technology

Oct. 25, 1999

Mechanistically novel iNOS inhibitors identified during Pharmacopeia/Berlex joint project

Oct. 22, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...